Emerging technologies should be considered as a possible additional intervention between the provider and patient to address HTN, thereby giving the provider additional tools to teach and evaluate the patient s progress. This recommendation s strength is Weak for. As this is a Reviewed, New-replaced recommendation, the Work Group systematically reviewed the relevant evidence for this recommendation identified in the evidence review conducted as part of this guideline update.[52,91-101] The overall confidence in the quality of the evidence is very low to low. While the balance of desirable and undesirable outcomes shows that benefits slightly outweigh harms/burden, there is a large variation of patient values and preferences. It cannot be understated that this recommendation has a broad scope with general findings that may show a modest benefit for those patients and providers who choose to utilize this medium. Technologies continue to evolve at a rapid pace and new capabilities are continually emerging. Additional studies should consider the effectiveness, safety, adherence, and overall quality of life impact on decreasing blood pressure. C. Non-pharmacological Management a. Weight Reduction The following recommendations are directed towards patients with HTN and overweight/obesity. There are benefits to weight reduction outside of treating for HTN. The various interventions may be more or less effective for other outcomes than for the treatment of HTN. Providers may refer to the VA/DoD Clinical Practice Guideline for Screening and Management of Obesity and Overweight for further discussion of treatment methods for patients with overweight/obesity.11 Recommendation 14. We suggest advising patients with hypertension and overweight/obesity to lose weight to improve blood pressure. (Weak for | Reviewed, Amended) Discussion As part of lifestyle modification, weight loss has been found to improve blood pressure in patients with HTN and overweight/obesity. 